Godavari Biorefineries bets big on bio-based future amid global energy shock
GBL's new grain-based distillery (200 KLPD) commissioning by June 2026 adds 60 MnL of capacity, timed perfectly for rising blending demand
GBL's new grain-based distillery (200 KLPD) commissioning by June 2026 adds 60 MnL of capacity, timed perfectly for rising blending demand
Transport Corporation of India reported consolidated revenue of Rs. 1,336 crore for the fourth quarter ended March 31, 2026
The partnership marks a major step in Evonik’s push to commercialize a new portfolio of sustainable chemistry solutions tailored specifically for mining operations
The program delivers OEM-certified remanufacturing that restores compressors to original factory specifications,
The company highlighted continued demand strength and pricing resilience despite global disruptions
Drawing a parallel with the Green Revolution, Agarwal said India now needs a similar transformation in minerals, metals, oil and gas
PETRONAS said full ownership will strengthen operational alignment across its value chain and improve flexibility
The partnership comes as automotive interiors rapidly evolve beyond static controls and displays
The move is being positioned as a preparatory step for potential future mergers
The machine is built to operate in extreme industrial conditions where human access is restricted or dangerous
The gathering was framed as a strategic response to fast-shifting business conditions
Additionally, UPL has expanded its Indian biosolutions portfolio by securing registration approvals for four new biostimulants
The current head of the division, Dr. Jeffrey Jianfeng Lou, will leave the company
Tritan gives us the performance needed to serve Europe’s evolving hospitality and retail markets
The decision removes import duties on essential inputs such as urea and ammonia
For the full year, volumes climbed 58.5% to 2,456 MW versus 1,550 MW in FY25
The Sugar, Power & Ethanol (SPE) division delivered record-breaking output
Additionally, we have signed a definitive agreement to acquire Bliss GVS Pharma which will further strengthen our pharmaceutical value chain capabilities
Developed entirely through in-house R&D, the new material is designed to give battery cell manufacturers a low-cost, graphite-free and more sustainable anode alternative
June 11, 2026 Connected Process Development through a Unified Digital Platform: Materials, Data, and Actionable Insights
Subscribe to our newsletter & stay updated.